Biote’s net revenue of $37 million was driven by 21.2% growth in Biote-partnered practitioner procedures, which is the core of our business. In our dietary supplement product line, our 2021 Black ...

IRVING, Texas--(BUSINESS WIRE)--Biote, a high growth, differentiated medical practice-building business within the hormone optimization space, today announced financial results for the second quarter ...

Biote CEO Terry Weber moved to Dallas from Orange County, Calif., in 2018 to lead the hormone replacement therapy provider into its next stage of growth. The Irving-based company is expecting up to ...

IRVING, Texas--(BUSINESS WIRE)-- biote Corp. (“Biote” or the “Company”), a high growth, differentiated medical practice-building business within the hormone optimization space, today announced that ...

Irving-based Biote went public via a SPAC merger in May. Now its founder, Dr. Gary Donovitz, said he signed off on the deal because he was misled. The founder of an Irving-based hormone optimization ...

IRVING, Texas--(BUSINESS WIRE)-- biote Corp., (Nasdaq: BTMD) (“Biote” or the “Company”), a high growth, differentiated medical practice-building business within the hormone optimization space, today ...

Biote Corp. ((BTMD)) has held its Q3 earnings call. Read on for the main highlights of the call. Biote Corp.’s latest earnings call revealed a mixed sentiment, with challenges and opportunities ...

CEO Bret Christensen noted that "the second quarter was pivotal for Biote as we implemented a strategic organizational restructuring designed to drive increased and sustainable growth." He highlighted ...